Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Viral Immunology
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1439328

Pro-inflammatory macrophages suppress HIV replication in humanized mice and ex vivo co-cultures

Provisionally accepted
Luca Baroncini Luca Baroncini Christina Muller Christina Muller Nicole P. Kadzioch Nicole P. Kadzioch Rebekka Wolfensberger Rebekka Wolfensberger Doris Russenberger Doris Russenberger Simon Bredl Simon Bredl Tafadzwa Mlambo Tafadzwa Mlambo Roberto F. Speck Roberto F. Speck *
  • University Hospital Zürich, Zurich, Switzerland

The final, formatted version of the article will be published soon.

    Very little is known about the role of macrophages as immune mediators during natural HIV infection. Humanized mice are a highly valuable in vivo model to study HIV pathogenesis. Still, the presence of murine mononuclear phagocytes in these models represents a significant limitation for the study of their human counterpart. Therefore, we developed a novel humanized mouse model, iHMD-NSG, which enables selective depletion of human myeloid cells at a time point of our choosing. These inducible human myeloid cell depletion (iHMD) mice showed specific human myeloid cell depletion with no adverse events for the animals. We used this model to show that human mononuclear phagocytes restrict HIV replication in vivo, which is accompanied by an increase in antiviral cytokines and chemokines. We found a similar HIV-inhibitory effect of macrophages in an ex vivo co-culture system, which was mediated by soluble factors. Transcriptomic data revealed the upregulation of antiviral cytokines and chemokines in macrophages of these co-culture experiments. RNA sequencing CD4+ T-cells showed cellular activation, up-regulation of HIV restriction factors and the downregulation of DNA transcription and RNA translation in the presence of macrophages. This work describes a novel role of macrophages as effector cells acting against HIV replication and disease progression.  

    Keywords: HIV-1, Macrophages, iHMD-NSG mice, humanized mice for HIV, Myeloid Cells

    Received: 27 May 2024; Accepted: 04 Oct 2024.

    Copyright: © 2024 Baroncini, Muller, Kadzioch, Wolfensberger, Russenberger, Bredl, Mlambo and Speck. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Roberto F. Speck, University Hospital Zürich, Zurich, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.